Bayer Group
Consolidated Statements of Comprehensive Income

 

 

 

 

 

 

 

 

 

3rd Quarter 2014

3rd Quarter 2015

 

First Nine Months 2014

First Nine Months 2015

 

 

€ million

€ million

 

€ million

€ million

1

Total changes recognized outside profit or loss

Income after income taxes

 

833

1,005

 

3,213

3,515

of which attributable to non-controlling interest

 

7

6

 

11

18

of which attributable to Bayer AG stockholders

 

826

999

 

3,202

3,497

 

 

 

 

 

 

 

Remeasurements of the net defined benefit liability for post-employment benefit plans

 

(1,529)

(647)

 

(4,089)

522

Income taxes

 

476

82

 

1,282

(237)

Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans

 

(1,053)

(565)

 

(2,807)

285

 

 

 

 

 

 

 

Other comprehensive income that will not be reclassified subsequently to profit or loss

 

(1,053)

(565)

 

(2,807)

285

 

 

 

 

 

 

 

Changes in fair values of derivatives designated as cash flow hedges

 

(125)

22

 

(178)

(235)

Reclassified to profit or loss

 

3

89

 

(73)

226

Income taxes

 

35

(45)

 

71

(14)

Other comprehensive income from cash flow hedges

 

(87)

66

 

(180)

(23)

 

 

 

 

 

 

 

Changes in fair values of available-for-sale financial assets

 

(1)

(3)

 

15

Reclassified to profit or loss

 

 

1

Income taxes

 

(2)

2

 

(3)

1

Other comprehensive income from available-for-sale financial assets

 

(3)

(1)

 

(3)

17

 

 

 

 

 

 

 

Changes in exchange differences recognized on translation of operations outside the eurozone

 

1,060

(361)

 

1,002

465

Reclassified to profit or loss

 

 

Other comprehensive income from exchange differences

 

1,060

(361)

 

1,002

465

 

 

 

 

 

 

 

Other comprehensive income that may be reclassified subsequently to profit or loss

 

970

(296)

 

819

459

 

 

 

 

 

 

 

Effects of changes in scope of consolidation

 

 

 

 

 

 

 

 

 

Total other comprehensive income1

 

(83)

(861)

 

(1,988)

744

of which attributable to non-controlling interest

 

5

(4)

 

9

4

of which attributable to Bayer AG stockholders

 

(88)

(857)

 

(1,997)

740

 

 

 

 

 

 

 

Total comprehensive income

 

750

144

 

1,225

4,259

of which attributable to non-controlling interest

 

12

2

 

20

22

of which attributable to Bayer AG stockholders

 

738

142

 

1,205

4,237